190 related articles for article (PubMed ID: 15219192)
21. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Di Minno G
Blood Rev; 2015 Jun; 29 Suppl 1():S26-33. PubMed ID: 26073366
[TBL] [Abstract][Full Text] [Related]
22. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
Poon MC; d'Oiron R; Hann I; Négrier C; de Lumley L; Thomas A; Karafoulidou A; Demers C; Street A; Huth-Kühne A; Petrini P; Fressinaud E; Morfini M; Tengborn L; Marquès-Verdier A; Musso R; Devecioglu O; Houston DS; Lethagen S; Van Geet C; von Depka M; Berger C; Beurrier P; Britton HA; Gerrits W; Guthner C; Kuhle S; Lorenzo JJ; Makris PE; Nohe N; Paugy P; Pautard B; Torchet MF; Trillot N; Vicariot M; Wilde J; Winter M; Chambost H; Ingerslev J; Peters M; Strauss G
Semin Hematol; 2001 Oct; 38(4 Suppl 12):21-5. PubMed ID: 11735106
[TBL] [Abstract][Full Text] [Related]
23. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
Dargaud Y; Bordet JC; Trzeciak MC; Vinciguerra C; Negrier C
Haematologica; 2006 Jun; 91(6 Suppl):ECR20. PubMed ID: 16785139
[TBL] [Abstract][Full Text] [Related]
24. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
[TBL] [Abstract][Full Text] [Related]
25. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
Kadowaki S; Makino S; Mohri Y; Awaguni H; Shinozuka J; Imashuku S
Blood Coagul Fibrinolysis; 2021 Mar; 32(2):155-158. PubMed ID: 33196513
[TBL] [Abstract][Full Text] [Related]
26. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
Erduran E; Aksoy A; Zaman D
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):215-7. PubMed ID: 19657319
[TBL] [Abstract][Full Text] [Related]
27. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
[TBL] [Abstract][Full Text] [Related]
28. Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders.
Chitlur M; Rajpurkar M; Recht M; Tarantino MD; Yee DL; Cooper DL; Gunawardena S
Int J Gen Med; 2017; 10():95-99. PubMed ID: 28435309
[TBL] [Abstract][Full Text] [Related]
29. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
[TBL] [Abstract][Full Text] [Related]
30. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
Andiç N; Oğuz N; Gündüz E; Kiraz Bulduk T; Üsküdar Teke H
Blood Coagul Fibrinolysis; 2021 Jul; 32(5):349-351. PubMed ID: 33878047
[TBL] [Abstract][Full Text] [Related]
31. Feminizing Genitoplasty in a young girl with Glanzmann's thrombasthenia-management of haemostasis.
Turk KK; Nazir Z
J Pak Med Assoc; 2020 Jun; 70(6):1084-1085. PubMed ID: 32810113
[TBL] [Abstract][Full Text] [Related]
32. Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.
Chuansumrit A; Suwannuraks M; Sri-Udomporn N; Pongtanakul B; Worapongpaiboon S
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):187-90. PubMed ID: 12632030
[TBL] [Abstract][Full Text] [Related]
33. Glanzmann's thrombasthenia proposed optimal management during surgery and delivery.
Bell JA; Savidge GF
Clin Appl Thromb Hemost; 2003 Apr; 9(2):167-70. PubMed ID: 12812388
[TBL] [Abstract][Full Text] [Related]
34. A patient with Glanzmann's thrombasthenia for emergent abdominal surgery.
Uzunlar HI; Eroglu A; Senel AC; Bostan H; Erciyes N
Anesth Analg; 2004 Oct; 99(4):1258-1260. PubMed ID: 15385386
[TBL] [Abstract][Full Text] [Related]
35. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Di Minno G; Zotz RB; d'Oiron R; Bindslev N; Di Minno MN; Poon MC;
Haematologica; 2015 Aug; 100(8):1031-7. PubMed ID: 26001793
[TBL] [Abstract][Full Text] [Related]
36. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
37. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
Birschmann I; Klamroth R; Eichler H; Schenk J; Kirchmaier CM; Halimeh S
Haemophilia; 2013 Sep; 19(5):679-85. PubMed ID: 23647644
[TBL] [Abstract][Full Text] [Related]
38. The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM; Khair K; Hann I; Liesner R
Br J Haematol; 2003 May; 121(3):477-81. PubMed ID: 12716372
[TBL] [Abstract][Full Text] [Related]
39. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
Yilmaz BT; Alioglu B; Ozyurek E; Akay HT; Mercan S; Ozbek N
Pediatr Cardiol; 2005; 26(6):843-5. PubMed ID: 15690232
[TBL] [Abstract][Full Text] [Related]
40. Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review.
Ganapule A; Jain P; Abubacker FN; Korula A; Abraham A; Mammen J; George B; Mathews V; Srivastava A; Viswabandya A
Blood Coagul Fibrinolysis; 2017 Mar; 28(2):171-175. PubMed ID: 27273143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
